This program is cosupported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; Genentech, a member of the Roche Group; GlaxoSmithKline; Jazz Pharmaceuticals, Inc.; and Mylan Specialty L.P.

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Ms Cartwright has no relevant financial relationships to disclose.

Dr Doghramji: consulting fees: Eisai, Idorsia, Imbrium, Pfizer; contracted research/consulting fees: Harmony, Jazz, Inspire; ownership interest: Merck.